These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2757672)

  • 61. The disposition of an antileishmanial 8-aminoquinoline drug in the isolated perfused rat liver: thermospray liquid chromatography-mass spectrometry identification of metabolites.
    Shipley LA; Coleman MD; Brewer TG; Ashmore RW; Theoharides AD
    Xenobiotica; 1990 Jan; 20(1):31-44. PubMed ID: 2327106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Metabolic products of methandrostenolone in the body of white rats studied by high-performance liquid chromatography].
    Krylov IuF; Krynetskiĭ EIu; Prokhorov BS; Sapozhnikova GA; Smirnov PA
    Farmakol Toksikol; 1988; 51(2):74-8. PubMed ID: 3378611
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Identification of efonidipine hydrochloride metabolites in rats.
    Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
    Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Disposition of 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5h)-furanone (mx) in b6c3f1 mice and f344 rats.
    Lebetkin EH; Chen LJ; Burka LT
    J Toxicol Environ Health A; 2002 Dec; 65(24):2101-18. PubMed ID: 12515589
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Disposition and metabolism of [14C]-amezinium metilsulfate in rats.
    Nambu K; Yoshida K; Kagemoto A; Matsumoto K; Miyazaki H; Hashimoto M; Esumi Y; Jin Y; Gunji S; Iwabuchi M
    Arzneimittelforschung; 1988 Jul; 38(7):909-18. PubMed ID: 3207436
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo metabolism of (+)-trans-delta-9-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Biomed Environ Mass Spectrom; 1988 Jan; 15(2):117-22. PubMed ID: 2832023
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Distribution, excretion, and metabolism of butylbenzyl phthalate in the rat.
    Eigenberg DA; Bozigian HP; Carter DE; Sipes IG
    J Toxicol Environ Health; 1986; 17(4):445-56. PubMed ID: 3959124
    [TBL] [Abstract][Full Text] [Related]  

  • 68. exo-Bicyclo(3.1.0)hexane-6-carboxylic acid and related compounds, oral hypoglycemic agents.
    Rynbrandt RH; Dutton FE; Schmidt FL
    J Med Chem; 1972 Apr; 15(4):424-6. PubMed ID: 5019566
    [No Abstract]   [Full Text] [Related]  

  • 69. Excretion of himantane and its metabolites with the urine and feces in rats.
    Litvin EA; Bastrygin DV; Kolyvanov GB; Alekseyev KV; Zherdev VP
    Bull Exp Biol Med; 2012 Aug; 153(4):481-2. PubMed ID: 22977850
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Preliminary open multicenter study on the anti-tremorigenic effectiveness of bornaprine (Sormodren)].
    Bergamasco B; Cantello R; Delsedime M; Gilli M; Riccio A; Aguggia M
    Minerva Med; 1985 Oct; 76(40):1877-81. PubMed ID: 4058785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Metabolic conversion of cyoctol during skin passage in humans.
    de Zeeuw RA; Herder RE; Wiechers JW; Drenth BF
    Pharm Res; 1990 Jun; 7(6):638-43. PubMed ID: 2367332
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The pharmacokinetics of adamantanes].
    Sergeeva SA; Krasnykh LM
    Eksp Klin Farmakol; 1994; 57(3):69-74. PubMed ID: 8049625
    [No Abstract]   [Full Text] [Related]  

  • 73. Liquid chromatographic determination of the concentration of a vinyl chloride-vinyl acetate copolymer in biological samples.
    Kimura M; Takashima M; Nakatani M; Kikkawa H; Nagao S; Itokawa Y
    J Chromatogr; 1984 Jul; 295(2):503-5. PubMed ID: 6470090
    [No Abstract]   [Full Text] [Related]  

  • 74. Enhanced 224Ra-212Pb excretion provoked by cryptating agents in rats.
    Müller WH
    Naturwissenschaften; 1974 Oct; 61(10):455. PubMed ID: 4422291
    [No Abstract]   [Full Text] [Related]  

  • 75. [The disposition of bornaprine hydrochloride in the rat. 1. Pharmacokinetics: synthesis, plasma level and elimination].
    Neidlein R; Pichler B; Hege G; Weymann J
    Arzneimittelforschung; 1989 Apr; 39(4):484-7. PubMed ID: 2751734
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans.
    Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA
    Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Microbial metabolism of bornaprine, 3-(diethylamino)propyl 2-phenylbicyclo[2.2.1]heptane-2-carboxylate.
    Elmarakby SA; Clark AM; Baker JK; Hufford CD
    J Pharm Sci; 1986 Jun; 75(6):614-8. PubMed ID: 3735109
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Anticholinergic activity of bornaprine and its metabolites in the isolated rat atrium.
    Hufford CD; Elmarakby SA; Walker LA
    Pharmacology; 1991; 42(1):23-7. PubMed ID: 2057518
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The disposition of bornaprine hydrochloride in the rat. 2. The metabolism of exo-epimers].
    Neidlein R; Pichler B; Hege G; Weymann J
    Arzneimittelforschung; 1989 May; 39(5):564-9. PubMed ID: 2757672
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.